Herpes simplex virus type 1 penetrates the basement membrane in human nasal respiratory mucosa

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Glorieux, Sarah ^a   Bachert, Claus ^b   Favoreel, Herman W ^a   Vandekerckhove, Annelies P ^a   Steukers, Lennert ^a   Rekecki, Anamaria ^a   van den Broeck, Wim ^a   Goossens, Joline ^a   Croubels, Siska ^a   Clayton, Reginald F ^c   Nauwynck, Hans J ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c TIBOTEC BVBA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASEMENT MEMBRANE; CELL ACTIVITY; DISEASE DURATION; EXPERIMENTAL MODEL; EXPLANT; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN TISSUE; LAMINA PROPRIA; NOSE MUCOSA; PATHOGENESIS; VIRUS CELL INTERACTION; VIRUS CULTURE; VIRUS ENTRY; VIRUS INFECTION; VIRUS MORPHOLOGY; VIRUS REPLICATION; VIRUS VIABILITY; BIOLOGICAL MODEL; EPITHELIUM; FLUORESCENCE; NICK END LABELING; PHYSIOLOGY; ULTRASTRUCTURE; VIROLOGY;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

BASEMENT MEMBRANE; EPITHELIUM; FLUORESCENCE; HERPESVIRUS 1, HUMAN; HUMANS; IN SITU NICK-END LABELING; MODELS, BIOLOGICAL; NASAL MUCOSA;

EID: 79960339318     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022160     Document Type: Article

References (59)

1. Marshall DS, Linfert DR, Draghi A, McCarter YS, Tsongalis GJ, (2001) Identification of herpes simplex virus genital infection: comparison of a multiplex PCR assay and traditional viral isolation techniques. Mod Pathol 14: 152-156.
2. Peña KC, Adelson ME, Mordechai E, Blaho JA, (2010) Genital herpes simplex virus type 1 in women: detection in cervicovaginal specimens from gynecological practices in the United States. J Clin Microbiol 48: 150-153.
3. Whitley RJ, (2001) Herpes simplex viruses. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martint MA, editors. Fields virology Philadelphia Lippincott, Williams, Wilkins pp. 2461-2509.
4. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, et al. (1997) Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 337: 1105-111.
5. Mitchell BM, Bloom DC, Cohrs RJ, Gilden DH, Kennedy PG, (2003) Herpes simplex virus-1 and varicella-zoster virus latency in ganglia. J Neurovirol 9: 194-204.
6. Pebody R, Andrews N, Brown D, Gopal R, de Melker H, et al. (2004) The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect 80: 185-191.
7. Stanberry LR, Cunningham AL, Mindel A, Scott LL, Spruance SL, et al. (2000) Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis 30: 549-566.
8. Whitley R, Arvin A, Prober C, Burchett S, Corey L, et al. (1991) A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious diseases collaborative antiviral study group. N Engl J Med 324: 444-449.
9. Betz UA, Fischer R, Kleymann G, Hendrix M, Rübsamen-Waigmann H, (2002) Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293. Antimicrob Agents Chemother 46: 1766-1772.
10. Greco A, Diaz JJ, Thouvenot D, Morfin F, (2007) Novel targets for the development of anti-herpes compounds. Infect Disord Drug Targets 7: 11-18.
11. Wang K, Mahalingam G, Hoover SE, Mont EK, Holland SM, et al. (2007) Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and ganglia. J Virol 81: 6817-6826.
12. Duan R, de Vries RD, Osterhaus ADME, Remeijer L, Verjans GMGM, (2008) Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis. J Infect Dis 198: 659-663.
13. Koelle DW, Corey L, (2003) Recent progress in herpes simplex virus immunobiology and vaccine research. Clin Microbiol Rev 16: 96-113.
14. Quondamatteo F, (2002) Assembly, stability and integrity of basement membranes in vivo. Histochem J 34: 369-381.
15. Kierszenbaum AL, (2007a) Respiratory system. Histology and cell biology: an introduction to pathology Philadelphia Mosby Elsevier pp. 371 p.
16. Kierszenbaum AL, (2007b) Epithelium. Histology and cell biology: an introduction to pathology Philadelphia Mosby Elsevier pp. 17-18.
17. Patel AR, Romanelli P, Roberts B, Kirsner RS, (2007) Treatment of herpes simplex virus infection: rationale for occlusion. Adv Skin Wound Care 20: 408-412.
18. Patel AR, Romanelli P, Roberts B, Kirsner RS, (2009) Herpes simplex virus: a histopathologic study of the depth of herpetic wounds. Int J Dermatol 48: 36-40.
19. McGill J, (1987) The enigma of herpes stromal disease. Br J Ophthalmol 71: 118-125.
20. Dingwell KS, Brunetti CR, Hendricks RL, Tang Q, Tang M, et al. (1994) Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J Virol 68: 834-845.
21. Polcicova K, Biswas PS, Banerjee K, Wisner TW, Rouse BT, et al. (2005) Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea. PNAS 102: 11462-11467.
22. Weeks BS, Ramchandran RS, Hopkins JJ, Friedman HM, (2000) Herpes simplex virus type-1 and-2 pathogenesis is restricted by the epidermal basement membrane. Arch Virol 145: 385-396.
23. Johnston C, Magaret A, Selke S, Remington M, Corey L, et al. (2008) Herpes simplex viremia during primary genital infection. J Infect Dis 198: 31-34.
24. Berrington WR, Jerome KR, Cook L, Wald A, Corey L, et al. (2009) Clinical correlates of herpes simplex virus viremia among hospitalized adults. Clin Infect Dis 49: 1295-1301.
25. Chen T, Hudnall SD, (2006) Anatomical mapping of human herpesvirus reservoirs of infection. Mod Pathol 19: 726-737.
26. Gizurarson S, Tamura S, Kurata T, Hasiguchi K, Ogawa H, (1991) The effect of cholera toxin and cholera toxin B subunit on the nasal mucosal membrane. Vaccine 9: 825-832.
27. Matter K, Balda MS, (2003) Functional analysis of tight junctions. Methods 30: 228-234.
28. Glorieux S, Van den Broeck W, van der Meulen KM, Van Reeth K, Favoreel HW, et al. (2007) In vitro culture of porcine respiratory nasal mucosa explants for studying the interaction of porcine viruses with the respiratory tract. J Virol Methods 142: 105-112.
29. Bradbury P, Gordon K, (1977) Connective tissues and stains. In: Bancroft JD, Stevens A, editors. Theory and practice of histological techniques New York Churchill Livingstone pp. 109-110.
30. Gartner LP, Hiatt JL, Strum JM, (2006) Cell biology and histology Hagerstwon Lippincott Williams & Wilkins.
31. Bradbury P, Gordon K, (1977) Connective tissues and stains. In: Bancroft JD, Stevens A, editors. Theory and practice of histological techniques New York Churchill Livingstone pp. 103 p.
32. King MA, (2000) Detection of dead cells and measurement of cell killing by flow cytometry. J Immunol Methods 243: 155-166.
33. Avlasevich SL, Bryce SM, Cairns SE, Dertinger SD, (2006) In vitro micronucleus scoring by flow cytometry: differential staining of micronuclei versus apoptotic and necrotic chromatin enhances assay reliability. Environ Mol Mutagen 47: 56-66.
34. Ham AW, Cormack DH, (1979) Loose connective tissue and basement membrane. Histology Philadelphia J.B. Lippincott Company pp. 222-224.
35. Schierhorn K, Brunnée T, Paus R, Schultz KD, Niehus J, et al. (1995) Gelatin sponge-supported histoculture of human nasal mucosa. In Vitro Cell Dev Biol Anim 31: 215-220.
36. Ali M, Maniscalco J, Baraniuk JN, (1996) Spontaneous release of submucosal gland serous and mucous cell macromolecules from human nasal explants in vitro. Am J Physiol 270: L595-L600.
37. Jackson AD, Rayner CFJ, Dewar A, Cole PJ, Wilson R, (1996) A human respiratory-tissue organ culture incorporating an air interface. Am J Respir Crit Care Med 153: 1130-1135.
38. Jang YJ, Lee SH, Kwon H-J, Chung Y-S, Lee B-J, (2005) Development of rhinovirus study model using organ culture of turbinate mucosa. J Virol Methods 125: 41-47.
39. Ingber DE, (2002) Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. Differentiation 70: 547-560.
40. Kissel T, Werner U, (1998) Nasal delivery of peptides: an in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium. J Control Release 53: 195-203.
41. Bernstein JM, Gorfien J, Noble B, Yankaskas JR, (1997) Nasal polyposis: immunohistochemistry and bioelectrical findings (a hypothesis for the development of nasal polyps). J Allergy Clin Immunol 99: 165-175.
42. Cotton CU, Stutts MJ, Knowles MR, Gatzy JT, Boucher RC, (1987) Abnormal apical cell membrane in cystic fibrosis respiratory epithelium. An in vitro electrophysiologic analysis. J Clin Invest 79: 80-85.
43. Glorieux S, Favoreel HW, Meesen G, de vos W, Van den Broeck W, et al. (2009) Different replication characteristics of historical pseudorabies virus strains in porcine respiratory nasal mucosa explants. Vet Microbiol 136: 341-346.
44. Steukers L, Vandekerckhove AP, Van den Broeck W, Glorieux S, Nauwynck HJ, (in press) Kinetics of BoHV-1 dissemination in an in vitro culture of bovine upper respiratory tract mucosa explants. ILAR e-J.
45. Vandekerckhove AP, Glorieux S, Gryspeerdt AC, Steukers L, Duchateau L, et al. (2010) Replication kinetics of neurovirulent versus non-neurovirulent equine herpesvirus type 1 strains in equine nasal mucosal explants. J Gen Virol 91: 2019-2028.
46. Landon DN, Langley OK, (1971) The local chemical environment of nodes of Ranvier: a study of cation binding. J Anat 108: 419-432.
47. Esaki S, Goshima F, Katsumi S, Watanabe D, Ozaki N, et al. (2010) Apoptosis induction after herpes simplex virus infection differs according to cell type in vivo. Arch Virol 55: 1235-1245.
48. Asano S, Honda T, Goshima F, Watanabe D, Miyake Y, et al. (1999) US3 potein kinase of herpes simplex virus type 2 plays a role in protecting corneal epithelial cells from apoptosis in infected mice. J Gen Virol 80: 51-56.
49. Miles DH, Willcox MD, Athmanathan S, (2004) Ocular and neuronal cell apoptosis during HSV-1 infection: a review. Curr Eye Res 29: 79-90.
50. Hata S, Koyama AH, Shiota H, Adachi A, Goshima F, et al. (1999) Antiapoptotic activity of herpes simplex virus type 2: the role of US3 protein kinase gene. Microbes Infect 1: 601-607.
51. Nguyen ML, Blaho JA, (2007) Apoptosis during herpes simplex virus infection. Adv Virus Res 69: 67-97.
52. Jerome KR, Fox R, Chen Z, Sears AE, Lee H, et al. (1999) Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J Virol 73: 8950-8957.
53. Perng GC, Jones C, Ciacci-Zanella J, Stone M, Henderson G, et al. (2000) Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287: 1500-1503.
54. Langelier Y, Bergeron S, Chabaud S, Lippens J, Guilbault C, et al. (2002) The R1 subunit of herpes simplex virus ribonucleotide reductase protects cells against apoptosis at, or upstream of, caspase-8 activation. J Gen Virol 83: 2779-2789.
55. Javouhey E, Gibert B, Arrigo AP, Diaz JJ, Diaz-Latoud C, (2008) Protection against heat and staurosporine mediated apoptosis by the HSV-1 US11 protein. Virology 376: 31-41.
56. Aubert M, Blaho JA, (1999) The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells. J Virol 73: 2803-2813.
57. Yamauchi Y, Daikoku T, Goshima F, Nishiyama Y, (2003) Herpes simplex virus UL14 protein blocks apoptosis. Microbiol Immunol 47: 685-689.
58. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, et al. (1998) Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94: 339-352.
59. Galvan V, Roizman B, (1998) Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc Natl Acad Sci USA 95: 3931-3936.